461 related articles for article (PubMed ID: 21832239)
21. Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.
Somers K; Kosciolek A; Bongers A; El-Ayoubi A; Karsa M; Mayoh C; Wadham C; Middlemiss S; Neznanov N; Kees UR; Lock RB; Gudkov A; Sutton R; Gurova K; Haber M; Norris MD; Henderson MJ
Int J Cancer; 2020 Apr; 146(7):1902-1916. PubMed ID: 31325323
[TBL] [Abstract][Full Text] [Related]
22. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
23. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.
Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J
Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769
[TBL] [Abstract][Full Text] [Related]
24. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
[TBL] [Abstract][Full Text] [Related]
25. Curaxin-Induced DNA Topology Alterations Trigger the Distinct Binding Response of CTCF and FACT at the Single-Molecule Level.
Lu K; Liu C; Liu Y; Luo A; Chen J; Lei Z; Kong J; Xiao X; Zhang S; Wang YZ; Ma L; Dou SX; Wang PY; Li M; Li G; Li W; Chen P
Biochemistry; 2021 Feb; 60(7):494-499. PubMed ID: 33570402
[TBL] [Abstract][Full Text] [Related]
26. Expression of FACT in mammalian tissues suggests its role in maintaining of undifferentiated state of cells.
Garcia H; Fleyshman D; Kolesnikova K; Safina A; Commane M; Paszkiewicz G; Omelian A; Morrison C; Gurova K
Oncotarget; 2011 Oct; 2(10):783-96. PubMed ID: 21998152
[TBL] [Abstract][Full Text] [Related]
27. Aaptamines from the marine sponge Aaptos sp. display anticancer activities in human cancer cell lines and modulate AP-1-, NF-κB-, and p53-dependent transcriptional activity in mouse JB6 Cl41 cells.
Dyshlovoy SA; Fedorov SN; Shubina LK; Kuzmich AS; Bokemeyer C; Keller-von Amsberg G; Honecker F
Biomed Res Int; 2014; 2014():469309. PubMed ID: 25215281
[TBL] [Abstract][Full Text] [Related]
28. Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin.
Sand-Dejmek J; Adelmant G; Sobhian B; Calkins AS; Marto J; Iglehart DJ; Lazaro JB
Mol Cancer; 2011 Jun; 10():74. PubMed ID: 21679440
[TBL] [Abstract][Full Text] [Related]
29. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
[TBL] [Abstract][Full Text] [Related]
30. p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.
Bohuslav J; Chen LF; Kwon H; Mu Y; Greene WC
J Biol Chem; 2004 Jun; 279(25):26115-25. PubMed ID: 15073170
[TBL] [Abstract][Full Text] [Related]
31. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
[TBL] [Abstract][Full Text] [Related]
32. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
Guo C; Gasparian AV; Zhuang Z; Bosykh DA; Komar AA; Gudkov AV; Gurova KV
Oncogene; 2009 Feb; 28(8):1151-61. PubMed ID: 19137016
[TBL] [Abstract][Full Text] [Related]
33. Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II.
Espinoza JA; Kanellis DC; Saproo S; Leal K; Martinez JF; Bartek J; Lindström MS
Nucleic Acids Res; 2024 May; 52(8):4151-4166. PubMed ID: 38340348
[TBL] [Abstract][Full Text] [Related]
34. Nuclear factor-kappaB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity.
Camarda G; Binaschi M; Maggi CA; Goso C
Int J Cancer; 2002 Dec; 102(5):476-82. PubMed ID: 12432549
[TBL] [Abstract][Full Text] [Related]
35. A novel drug discovery strategy: mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways.
Zhuang C; Sheng C; Shin WS; Wu Y; Li J; Yao J; Dong G; Zhang W; Sham YY; Miao Z; Zhang W
Oncotarget; 2014 Nov; 5(21):10830-9. PubMed ID: 25350970
[TBL] [Abstract][Full Text] [Related]
36. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
Dejmek J; Iglehart JD; Lazaro JB
Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
[TBL] [Abstract][Full Text] [Related]
37. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
[TBL] [Abstract][Full Text] [Related]
38. p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.
Keller DM; Lu H
J Biol Chem; 2002 Dec; 277(51):50206-13. PubMed ID: 12393879
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
[TBL] [Abstract][Full Text] [Related]
40. The anti-cancer drugs curaxins target spatial genome organization.
Kantidze OL; Luzhin AV; Nizovtseva EV; Safina A; Valieva ME; Golov AK; Velichko AK; Lyubitelev AV; Feofanov AV; Gurova KV; Studitsky VM; Razin SV
Nat Commun; 2019 Mar; 10(1):1441. PubMed ID: 30926878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
